Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 18.7B | 19.2B | 16.7B | 17.8B |
| Cost of revenue | 16.2B | 16.9B | 14.0B | 15.1B |
| Gross profit | 2.5B | 2.3B | 2.7B | 2.7B |
| Operating expense | ||||
| Research & development | — | 274.0M | 186.8M | 178.4M |
| Selling general and admin | 1.1B | 412.6M | 385.6M | 370.5M |
| Other operating expenses | — | 132.7M | 39.9M | -15.3M |
| Operating income | 2.5B | 980.8M | 1.6B | 1.6B |
| Non operating interest income | ||||
| Income | — | 81.9M | 84.5M | 81.0M |
| Expense | — | 23.1M | 28.5M | 29.8M |
| Other income expense | — | — | — | — |
| Pretax income | 1.7B | 930.8M | 1.5B | 1.4B |
| Tax provision | 255.4M | 19.2M | 67.4M | 92.6M |
| Net income | 1.5B | 911.6M | 1.4B | 1.3B |
| Basic EPS | 47.9 | — | 47 | 44 |
| Diluted EPS | 47.9 | — | 47 | 44 |
| Basic average shares | — | — | 30.8M | 30.2M |
| Diluted average shares | — | — | 30.8M | 30.2M |
| EBITDA | 2.5B | 1.8B | 2.3B | 2.2B |
| Net income from continuing op. | — | 911.6M | 1.4B | 1.3B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |